Molecular Targeted Therapy in the Treatment of Chordoma: A Systematic Review
Objectives: Chordoma is a rare bone malignancy that affects the spine and skull base. Treatment dilemma leads to a high rate of local relapse and distant metastases. Molecular targeted therapy (MTT) is an option for advanced chordoma, but its therapeutic efficacy and safety have not been investigate...
Main Authors: | Tong Meng, Jiali Jin, Cong Jiang, Runzhi Huang, Huabin Yin, Dianwen Song, Liming Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00030/full |
Similar Items
-
Sustained Response of a Clivus Chordoma to Erlotinib after Imatinib Failure
by: Aline Houessinon, et al.
Published: (2015-01-01) -
Chordoma: retrospective analysis of 24 cases
by: Ademar Lopes, et al. -
Skull base chordomas review of current treatment paradigms
by: Dan Yaniv, et al.
Published: (2020-06-01) -
Perineal chordoma cutis, a rare localization for a rare pathology: a case report and consideration of the literature
by: Chennoufi Mehdi, et al.
Published: (2020-05-01) -
A retrorectal tumor: Presacral chordoma
by: Suresh Birur Parmeshwarappa, et al.
Published: (2013-01-01)